Effects of thienorphine on synaptic structure and synaptophysin expression in the rat nucleus accumbens

Neuroscience

Volumn 274, Issue , 2014, Pages 53-58

  Yong, Z ^a   Yan, L ^a   Gao, X ^a   Gong, Z ^a   Su, R ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Nucleus accumbens; Synaptic plasticity; Synaptic structure; Synaptophysin; Thienorphine

Indexed keywords

MORPHINE; OPIATE AGONIST; SYNAPTOPHYSIN; THIENORPHINE; UNCLASSIFIED DRUG; BUPRENORPHINE; NARCOTIC ANALGESIC AGENT; SYP PROTEIN, RAT;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; MALE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; STRUCTURE ANALYSIS; ULTRASTRUCTURE; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; METABOLISM; SYNAPSE; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; MALE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; SYNAPSES; SYNAPTOPHYSIN;

EID: 84902097429     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.05.026     Document Type: Article

References (30)

1. Alcantara A.A., Lim H.Y., Floyd C.E., Garces J., Mendenhall J.M., Lyons C.L., Berlanga M.L. Cocaine- and morphine-induced synaptic plasticity in the nucleus accumbens. Synapse 2011, 65:309-320.
2. Bradford M. A refined sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976, 72:248-254.
3. Cheskin L.J., Fudala P.J., Johnson R.E. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug Alcohol Depend 1994, 36:115-121.
4. De Biasi M., Dani J.A. Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci 2011, 34:105-130.
5. Guldner F.H. Increase in postsynaptic density material in optic target neuron of the rat suprachiasmatic nucleus after bilateral enucleation. Neurosci Lett 1980, 17:27-32.
6. Heel R.C., Brogden R.N., Speight T.M., Avery G.S. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs 1979, 17:81-110.
7. Jing Y., Wang Z., Song Y. Quantitative study of aluminum-induced changes in synaptic ultrastructure in rats. Synapse 2004, 52:292-298.
8. Jones D.G., Devon R.M. An ultrastructural study into the effect of pentobarbitone on synaptic organization. Brain Res 1978, 147:47-63.
9. Kennedy M.B. Signal-processing machines at the postsynaptic density. Science 2000, 290:750-754.
10. Klauck T.M., Scott J.D. The postsynaptic density: a subcellular anchor for signal transduction enzymes. Cell Signal 1995, 7:747-757.
11. Kong Q., Qiao J., Wang X., Yuan S., Zhang Z., Gong Z., Ruan J. Simultaneous determination of thienorphine and its active metabolite thienorphine glucuronide in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies. J Chromatogr B Analy Technol Biomed Life Sci 2007, 859:52-61.
12. Kwon S.E., Chapman E.R. Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron 2011, 70:847-854.
13. Li K.W., Jimenez C.R., van der Schors R.C., Hornshaw M.P., Schoffelmeer A.N., Smit A.B. Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 2006, 6:2003-2008.
14. Liang Y.J., Wu D.F., Yang L.Q., Höllt V., Koch T. Interaction of the mu-opioid receptor with synaptophysin influences receptor trafficking and signaling. Mol Pharmacol 2007, 71:123-131.
15. Liu C.H., Liu H., Han X.Y., Wu B., Zhong B.H., Gong Z.H. Synthesis and characterization of thienorphine and its glucuronide conjugate. Synth Commun 2005, 35:701-710.
16. Lüscher C., Malenka R.C. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 2011, 69:650-663.
17. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, San Diego. 6th ed.
18. Prokai L., Zharikova A.D., Stevens S.M. Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. J Mass Spectrum 2005, 40:169-175.
19. Robinson T.E., Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 1999, 33:160-162.
20. Russo S.J., Mazei-Robison M.S., Ables J.L., Nestler E.J. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 2009, 56(Suppl. 1):73-82.
21. Scheiffele P. Cell-cell signaling during synapse formation in the CNS. Annu Rev Neurosci 2003, 26:485-508.
22. Sudhof T.C. The synaptic vesicle cycle. Annu Rev Neurosci 2004, 27:509-547.
23. Takagi N., Logan R., Teves L., Wallace M.C., Gurd J.W. Altered interaction between PSD-95 and the NMDA receptor following transient global ischemia. J Neurochem 2000, 74:169-178.
24. Thiele C., Hannah M., Fahrenholz F., Huttner W.B. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol 2000, 2:42-49.
25. Trinidad J.C., Thalhammer A., Specht C.G., Schoepfer R., Burlingame A.L. Phosphorylation state of postsynaptic density proteins. J Neurochem 2005, 92:1306-1316.
26. Wilbrecht L., Holtmaat A., Wright N., Fox K., Svoboda K. Structural plasticity underlies experience-dependent functional plasticity of corticalcircuits. J Neurosci 2010, 30:4927-4932.
27. Xu L., Anwyl R., Rowan M.J. Behavioural stress facilitates the induction of long-term depression in the hippocampus. Nature 1997, 387:497-500.
28. Yong Z., Yan L.D., Dong Z.Q., Wang X., Su R.B., Gong Z.H. The effect of chronic thienorphine administration on long-term potentiation and synaptic structure in rat hippocampus. Synapse 2013, 67:779-785.
29. Yu G., Yue Y.J., Cui M.X., Gong Z.H. Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine. J Pharmacol Exp Ther 2006, 318:282-287.
30. Zhao W.L., Gong Z.H., Liang J.H. A new buprenorphine analogy, thenorphine, inhibits morphine-induced behavioral sensitization in mice. Acta Pharmacol Sin 2004, 25:1413-1418.